Method for amplification of endothelial progenitor cell in vitro
First Claim
1. A method for preparing endothelial progenitor cells, which comprises incubating CD34 positive and/or CD133 positive cells in a serum-free culture medium containing stem cell factor, interleukin-6, FMS-like tyrosine kinase 3 ligand, thrombopoietin and vascular endothelial growth factor, whereby the number of endothelial progenitor cells contained in the CD34 positive and/or CD133 positive cells is increased.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a method for expanding an endothelial progenitor cell in vitro. More particularly, the present invention provides a method for culturing a hemangioblast comprising incubating a hemangioblast in a serum-free culture medium containing one or more factors selected from the group consisting of stem cell growth factor, interleukin-6, FMS-like tyrosine kinase 3 and thrombopoietin, and a vascular endothelial cell produced by the method; and a serum-free culture medium containing one or more factors selected from the group consisting of stem cell growth factor, interleukin-6, FMS-like tyrosine kinase 3 ligand and thrombopoietin, and a kit for the preparation of the serum-free culture medium and the like.
-
Citations
8 Claims
- 1. A method for preparing endothelial progenitor cells, which comprises incubating CD34 positive and/or CD133 positive cells in a serum-free culture medium containing stem cell factor, interleukin-6, FMS-like tyrosine kinase 3 ligand, thrombopoietin and vascular endothelial growth factor, whereby the number of endothelial progenitor cells contained in the CD34 positive and/or CD133 positive cells is increased.
Specification